Fasching CL - Search Results

1

Telomere maintenance by recombination in human cells.

Dunham MA, Neumann AA, Fasching CL, Reddel RR. Dunham MA, et al. Among authors: fasching cl. Nat Genet. 2000 Dec;26(4):447-50. doi: 10.1038/82586. Nat Genet. 2000. PMID: 11101843

2

Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.

Fasching CL, Bower K, Reddel RR. Fasching CL, et al. Cancer Res. 2005 Apr 1;65(7):2722-9. doi: 10.1158/0008-5472.CAN-04-2881. Cancer Res. 2005. PMID: 15805271

3

DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.

Fasching CL, Neumann AA, Muntoni A, Yeager TR, Reddel RR. Fasching CL, et al. Cancer Res. 2007 Aug 1;67(15):7072-7. doi: 10.1158/0008-5472.CAN-07-1556. Epub 2007 Jul 24. Cancer Res. 2007. PMID: 17652140

4

Pictures in Molecular Medicine: Telomeres copying telomeres in human cells.

Neumann A, Fasching C. Neumann A, et al. Trends Mol Med. 2001 Apr;7(4):184. doi: 10.1016/s1471-4914(01)01964-5. Trends Mol Med. 2001. PMID: 11286945 No abstract available.

5

Functional evidence for a breast cancer growth suppressor gene on chromosome 17.

Casey G, Plummer S, Hoeltge G, Scanlon D, Fasching C, Stanbridge EJ. Casey G, et al. Hum Mol Genet. 1993 Nov;2(11):1921-7. doi: 10.1093/hmg/2.11.1921. Hum Mol Genet. 1993. PMID: 8281156

6

Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT.

Boukamp P, Popp S, Altmeyer S, Hülsen A, Fasching C, Cremer T, Fusenig NE. Boukamp P, et al. Genes Chromosomes Cancer. 1997 Aug;19(4):201-14. doi: 10.1002/(sici)1098-2264(199708)19:4<201::aid-gcc1>3.0.co;2-0. Genes Chromosomes Cancer. 1997. PMID: 9258654

7

Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.

Plattner R, Anderson MJ, Sato KY, Fasching CL, Der CJ, Stanbridge EJ. Plattner R, et al. Among authors: fasching cl. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6665-70. doi: 10.1073/pnas.93.13.6665. Proc Natl Acad Sci U S A. 1996. PMID: 8692875 Free PMC article.

8

Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines.

Sato KY, Polakis PG, Haubruck H, Fasching CL, McCormick F, Stanbridge EJ. Sato KY, et al. Among authors: fasching cl. Cancer Res. 1994 Jan 15;54(2):552-9. Cancer Res. 1994. PMID: 8275494

9

Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.

Mendonca MS, Fasching CL, Srivatsan ES, Stanbridge EJ, Redpath JL. Mendonca MS, et al. Among authors: fasching cl. Radiat Res. 1995 Jul;143(1):34-44. Radiat Res. 1995. PMID: 7597142

10

Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080.

Anderson MJ, Casey G, Fasching CL, Stanbridge EJ. Anderson MJ, et al. Among authors: fasching cl. Genes Chromosomes Cancer. 1994 Apr;9(4):266-81. doi: 10.1002/gcc.2870090407. Genes Chromosomes Cancer. 1994. PMID: 7519049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results